Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons. - Wikidata - wikimedia - TriplyDB

Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons.

Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons.

http://www.wikidata.org/entity/Q34469459

about

A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications Modeling psychiatric disorders for developing effective treatments The long non-coding RNA NEAT1 is responsive to neuronal activity and is associated with hyperexcitability states Genetically-Informed Patient Selection for iPSC Studies of Complex Diseases May Aid in Reducing Cellular Heterogeneity.Induced Pluripotent Stem Cells: Global Research Trends.Connectivity and circuitry in a dish versus in a brain Probing disorders of the nervous system using reprogramming approaches.Altered WNT Signaling in Human Induced Pluripotent Stem Cell Neural Progenitor Cells Derived from Four Schizophrenia Patients.Neuropeptidomics Mass Spectrometry Reveals Signaling Networks Generated by Distinct Protease Pathways in Human Systems.Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders.Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients.Modeling psychiatric disorders: from genomic findings to cellular phenotypes Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders.Analysis of induced pluripotent stem cells carrying 22q11.2 deletion.Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.A Single-Cell Roadmap of Lineage Bifurcation in Human ESC Models of Embryonic Brain Development.The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders.Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons.Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence.Controlling the Regional Identity of hPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes.Disease modelling using human iPSCs.Differential Maturation of the Two Regulated Secretory Pathways in Human iPSC-Derived Neurons.Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders.The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.Modeling neurodevelopmental and psychiatric diseases with human iPSCs.Pluripotent stem cells in neuropsychiatric disorders.Human induced pluripotent stem cells for modelling neurodevelopmental disorders.Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs).Abnormally Increased Secretion in Olfactory Neuronal Precursors from a Case of Schizophrenia Is Modulated by Melatonin: A Pilot Study Dopaminergic differentiation of schizophrenia hiPSCs Activity-Dependent Changes in Gene Expression in Schizophrenia Human-Induced Pluripotent Stem Cell Neurons.Using Human iPSC-Derived Neurons to Uncover Activity-Dependent Non-Coding RNAs.Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.Modeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells.New considerations for hiPSC-based models of neuropsychiatric disorders.THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders.Diversity of Neuropeptide Cell-Cell Signaling Molecules Generated by Proteolytic Processing Revealed by Neuropeptidomics Mass Spectrometry.Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells

P2860

Q26770097-10B76DC4-3B0E-42E6-A736-AF5154725810 Q26772309-994C19E8-270A-4373-BE77-8D3E5AF7EBED Q26784269-5004C0E2-414A-4CE9-A073-ACACCFC71594 Q30833802-9A61FFAB-4B7C-432C-A2AC-E928BC2916BF Q33790547-9383F3E0-B073-4E46-BB34-B806C0F541C3 Q33914515-F188F11B-8CF2-40AD-8D07-3F49E8954B41 Q35684598-27A83AF3-6C08-43E1-82B5-58B29CD16FEA Q35761135-BF8F9AA0-5E7C-4043-ACD7-71766D0F4B67 Q35904650-3D258E50-5D4D-4F59-B4E5-802DB57DE35F Q36568097-80209EEA-A952-4D5C-9B19-FBD530ECFEAD Q36717285-E83D6923-4471-4A76-9452-AEB6DEE586CA Q37058606-100991B8-EC59-4A61-BE6D-79A567CA314C Q37199033-A7EE1CF5-26CB-4D5C-9FDD-7CFD2FD2FD5F Q37344763-D9D61D3D-77FA-4E7C-9108-F33D6B43DCE2 Q37648244-6324C180-CFE2-4B2A-AB29-304C9EFCDC77 Q38358569-CC6A07C0-3C81-4A01-94A1-9A7361D2D458 Q38637625-5A86E6FC-5A53-4FBD-B856-69B041364436 Q38720999-9D79C57E-EFEB-4DBA-9C8E-E099DA9B536F Q38790294-B5B73CAC-57AE-4D5B-952C-CA7C90A18C57 Q38807798-7B54B3DC-CBAD-4034-B295-5931723D4DD2 Q38809416-DFBF9F8A-E62F-4B86-A09C-039717E9EB17 Q38820880-AA7A8574-0E58-44EC-99FF-9D3B71B53C6F Q38919220-88A35925-CBAA-4B7E-B6C7-6D7C0B8ED5AA Q38941320-57D28DBF-DE9A-48A3-9948-CABD717AB212 Q38964644-D7751C24-DEE4-480A-AA6F-034BFC574888 Q38976291-04C87AB5-35CE-4374-9B35-4B346FECF8F5 Q39130188-F6A90359-EEDD-417C-9790-D2876F86F0A3 Q39189500-F87ADFA5-F86A-44F9-BBB2-81F16457E798 Q39247913-72AEF206-3B88-4E1F-8A78-7814C534CF9A Q39408715-725435A3-3C83-4AA3-81CD-41BF20A8B956 Q41182099-A547C6BB-A451-4CC0-B372-1332090A48B2 Q42331751-E3302FBC-B705-4CDC-9205-67D26405C6E8 Q43062745-6682FED5-B717-4D3B-AE0A-830FBD106333 Q47904811-B74832C3-A131-4B9D-809D-54B9F0735EFA Q48931004-9B19E5D0-F6E2-4E66-86C2-F9474FEDCBDE Q49601349-235F6037-D4CB-48F5-AA7F-0652FDB0E0FF Q52372478-9FF63E31-406E-4C4A-9950-32D2657FAD29 Q52565505-A7CBC4B4-1267-434A-A2E2-B100CAD1075D Q52581456-63C3A22C-A0F0-43B2-A2EE-0A8E8D0F494D Q58730340-69D5C5A9-068C-40B2-92DB-49F69024E6DE

P2860

Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons.

http://www.wikidata.org/entity/Q34469459

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@ast

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@en

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@nl

type

label

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@ast

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@en

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@nl

prefLabel

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@ast

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@en

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@nl

P1433

Q34469459-803FF557-7148-49ED-8F12-BE95FFEB4ED0

P1476

Q34469459-46039009-471E-4ED2-99BF-28918EAD8A08

P2093

Q34469459-08DB3C34-1603-4EE1-AB51-7A7AC86FD08B

Q34469459-17BDE6BC-AD21-4944-BEEF-BDB243B049A8

Q34469459-9449E381-96EA-4520-8BD4-7ABD6F932DD5

Q34469459-A5224AC7-EACC-43B0-8FDF-8A0CDE73722A

Q34469459-C5431D64-B6C4-404E-8EA7-3252D3262E0A

Q34469459-D3E3ED89-3423-4F04-A0DE-48A9BF885E02

Q34469459-E00ADEE6-B286-4C56-9C4C-46053AB9AC3A

P2860

Q34469459-17D7CBB8-B7DA-4A93-B6E9-C1C9C31DEC8B

Q34469459-1F70E947-AE50-441A-8FFA-550FD66639DE

Q34469459-2DE5284D-73E4-4735-B088-A8C55DDEB97A

Q34469459-30C32902-4F40-4DED-977E-47E130B564CD

Q34469459-3198EB5B-D83F-4147-81E1-F37E844D294B

Q34469459-33146DB0-C431-47E7-864E-D4C52D72CEE1

Q34469459-33C061BB-2240-4886-B478-653A57154D5D

Q34469459-352D16DE-62EF-4E9E-9519-AC607EFF9969

Q34469459-35A156EB-B19C-4B13-8E12-868316542D89

Q34469459-429A5F21-08F3-4997-B0EF-DF78215181A6

P304

Q34469459-04566767-B52E-4F13-B25F-6748025079E5

P31

Q34469459-677200AD-F2AC-48E1-8538-28CDC5D3B2C7

P356

Q34469459-AC1CD67B-5367-430A-A3EF-ED88D9959E9B

P433

Q34469459-049BC484-F27F-4677-9BA6-4057957DCA26

P478

Q34469459-8ABD800C-A211-4373-B045-BCA88A178F06

P50

Q34469459-CE2DFFCA-8291-47C8-931E-978BCC8BF8D1

P577

Q34469459-36463ADE-C808-4433-AC7D-900D13666028

P5875

Q34469459-092C7861-B66C-45EF-BA70-4DA0F03A19DF

P698

Q34469459-71516E9C-0045-4253-92CA-A2CD81F42954

P921

Q34469459-39048E28-2061-4F99-A93C-4C9080B0D384

Q34469459-84D3F9EF-7AED-492D-914C-E3EFE5176834

P932

Q34469459-B64F850F-3F81-4F6D-80C0-11934BECAC08

P356

J.STEMCR.2014.08.001

P1433

Stem Cell Reports

P1476

Human iPSC neurons display act ...... vels in schizophrenia neurons.

@en

P2093

Fred H Gage

http://www.w3.org/2001/XMLSchema#string

Kelly C Lee

http://www.w3.org/2001/XMLSchema#string

Lydiane Funkelstein

http://www.w3.org/2001/XMLSchema#string

Michael Ziegler

http://www.w3.org/2001/XMLSchema#string

Thomas Toneff

http://www.w3.org/2001/XMLSchema#string

Vivian Hook

http://www.w3.org/2001/XMLSchema#string

Yongsung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Modelling schizophrenia using human induced pluripotent stem cells.

Mouse pharmacological models of cognitive disruption relevant to schizophrenia.

Progress toward the clinical application of patient-specific pluripotent stem cells

Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia.

Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase.

Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models.

Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra.

Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters.

Alzheimer's disease in a dish: promises and challenges of human stem cell models.

NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia

P304

531-538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEMCR.2014.08.001

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Kristen J. Brennand

P577

2014-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266677684

http://www.w3.org/2001/XMLSchema#string

P698

25358781

http://www.w3.org/2001/XMLSchema#string

P921

neurotransmitter

P932

4223699

http://www.w3.org/2001/XMLSchema#string